{"id":"W2126565162","doi":"10.1093/annonc/mdm554","title":"A phase II study of sorafenib in patients with chemo-naive castration-resistant prostate cancer","year":2007,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":118,"is_retracted":false,"has_abstract":false,"ca_institutions":"Ontario Institute for Cancer Research; Queen's University; University Health Network; Hamilton Health Sciences; Juravinski Cancer Centre; CancerCare Manitoba; Princess Margaret Cancer Centre; BC Cancer Agency","funders":"","keywords":"Medicine; Sorafenib; Prostate cancer; Internal medicine; Prostate-specific antigen; Discontinuation; Oncology; Clinical endpoint; Adverse effect; Urology; Cancer; Clinical trial; Hepatocellular carcinoma","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001646426,0.001914401,0.003673094,0.0005394997,0.0006462655,0.001155873,0.000842764,0.001245982,0.00399783],"category_scores_gemma":[0.00134394,0.0008688138,0.002374614,0.0005343141,0.001452691,0.001400284,0.0004354272,0.004064803,0.0009316413],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009606864,"about_ca_system_score_gemma":0.002000513,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001905344,"about_ca_topic_score_gemma":0.004945029,"domain_scores_codex":[0.9993599,0.0003256463,0.00002765167,0.0000962089,0.00003883494,0.000151731],"domain_scores_gemma":[0.9987937,0.0002277574,0.000154151,0.00009580785,0.00006074065,0.0006678122],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.9034184,0.03385774,0.00388569,0.0005669466,0.001282294,0.0002102779,0.0002901556,0.0016609,0.01250742,0.0001796631,0.001854754,0.0402857],"study_design_scores_gemma":[0.7749354,0.2161424,0.005924618,0.00001467459,0.0003714408,0.000146838,0.00008284589,0.0005566704,0.0007712952,0.0001268825,0.0008997383,0.00002718126],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9946927,0.001511644,0.0003548108,0.0005161915,0.0001895731,0.001241787,0.0005245139,0.00006478911,0.0009038529],"genre_scores_gemma":[0.9930922,0.001495587,0.0007636138,0.0005129089,0.0002224294,0.001185755,0.001135272,0.00002767792,0.001564486],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00399783,"threshold_uncertainty_score":0.01337409,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08156833559138355,"score_gpt":0.4511618509292627,"score_spread":0.3695935153378792,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}